Description

Dasatinib CAS NO 302964-06-3 is a potent, orally bioavailable, multi-targeted kinase inhibitor of the BCR-ABL and Src family kinases. This compound is of critical importance in pharmaceutical research and development as a key active pharmaceutical ingredient (API) for targeted cancer therapy. It is primarily required by pharmaceutical manufacturers, research institutions, and contract development and manufacturing organizations (CDMOs) engaged in the development and production of oncology treatments.

Application

• Active Pharmaceutical Ingredient (API) in the manufacture of targeted cancer therapeutics.
• Key intermediate in advanced pharmaceutical synthesis and process development.
• Reference standard for analytical method development and quality control in pharmaceutical laboratories.
• Biochemical research tool for studying BCR-ABL and Src family kinase signaling pathways.
• Pre-clinical and clinical research material for oncology drug discovery programs.
• Component in the development of novel drug formulations and combination therapies.

Basic Information

Product Name	Dasatinib
CAS No.	302964-06-3
Molecular Formula	C22H26ClN7O2S
Molecular Weight	488.01 g/mol
Synonyms	BMS-354825; Sprycel; N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide; Dasatinib Monohydrate; Dasatinib Anhydrous
EINECS	Contact for details

Quality Control

Our Dasatinib is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing to ensure it meets high-purity standards suitable for pharmaceutical research and development. Certificates of Analysis (COA) detailing purity, identity, and impurity profiles are provided with every shipment to guarantee traceability and batch-to-batch consistency.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). Keep the container tightly sealed in a dry environment to maintain stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time corresponds to reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Single Unknown Impurity	≤ 0.5%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.